Description |
2,4-dienoyl-CoA reductase 1 |
matrix metallopeptidase 16 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Autism spectrum disorder or schizophrenia ( 28540026)
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885)
- Bipolar disorder ( 31043756)
- Body mass index and cholesterol (psychopharmacological treatment) ( 22417934)
- Body shape index ( 34021172)
- Cerebral amyloid deposition (PET imaging) ( 26252872)
- Cough in response to angiotensin-converting enzyme inhibitor drugs ( 28084903)
- Heel bone mineral density ( 30598549)
- Irritable mood ( 29500382)
- Migraine without aura ( 23793025)
- Refractive error ( 32231278)
- Schizophrenia ( 28991256 25056061 21926974 29483656 22688191 30285260 23974872)
- Sweet taste perception in obesity with metabolic syndrome ( 31005965)
- Waist circumference adjusted for body mass index ( 34021172)
- Waist-hip index ( 34021172)
- Waist-to-hip ratio adjusted for BMI ( 34021172)
|
Interacting Genes |
4 interacting genes:
APP
CLCN3
HGS
MMP16
|
5 interacting genes:
DECR1
DNAAF5
KISS1
LRP1
PIP4P2
|
Entrez ID |
1666 |
4325 |
HPRD ID |
01959 |
03776 |
Ensembl ID |
ENSG00000104325
|
ENSG00000156103
|
Uniprot IDs |
A0A024R9D7
Q16698
|
P51512
|
PDB IDs |
1W6U
1W73
1W8D
|
1RM8
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|